$6.31
0.060.96%
At Close: -
$6.31
00.00%
After Hours: Jul 3, 2:50 PM EDT
15 minutes delayed
Candel Therapeutics
CADLNASDAQ
Latest news for Candel Therapeutics (NASDAQ:CADL) Stock
Candel Therapeutics Stock (NASDAQ: CADL)
Categories: All
Thursday, June 13, 2024
Tuesday, June 11, 2024
Monday, June 03, 2024
Thursday, May 30, 2024
Monday, May 27, 2024
Friday, May 24, 2024
Thursday, May 23, 2024
Wednesday, May 22, 2024
Wednesday, May 15, 2024
Tuesday, May 14, 2024
Friday, April 19, 2024
Thursday, April 11, 2024
- Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- What's Going On With Candel Therapeutics Stock?
- Candel Therapeutics shares are trading higher...
- Candel Therapeutics Receives FDA Orphan Drug ...
Tuesday, April 09, 2024
Friday, April 05, 2024
- 12 Health Care Stocks Moving In Friday's Intraday Session
- Candel Therapeutics Shares Resume Trading
- Candel Therapeutics Shares Halted On Circuit ...
- Candel Therapeutics Shares Resume Trade
- Candel Therapeutics Shares Halted On Circuit ...
- What's Going On With Candel Therapeutics Stock On Friday?
- CORRECTION: Candel Therapeutics Announced Int...
- Candel Therapeutics shares are trading higher...
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Ford, Candel Therapeutics, Nvidia, Palantir, Tesla: Why These 5 Stocks Are On Investors' Radars Today
Thursday, April 04, 2024
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Dow Dips Over 200 Points; RPM International Shares Fall After Q3 Results
- Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Nasdaq Surges 1%; ConAgra Brands Posts Upbeat Earnings
- After Brain Cancer Data, Candel Therapeutics' Shares Good News From Pancreatic Cancer Study
- Market-Moving News for April 4th
- 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- Candel Therapeutics Announces Interim Data Fr...